Literature DB >> 24847130

Response to Sexton: Inhibiting the renin-angiotensin-aldosterone system in patients with heart failure and renal dysfunction: common sense or nonsense?

Javed Butler1, Michael M Givertz2.   

Abstract

Entities:  

Keywords:  angiotensin receptor antagonists; angiotensin-converting enzyme inhibitors; heart failure; hypotension; mineralocorticoid receptor antagonists; renal insufficiency; renin–angiotensin system

Mesh：

Year:  2014        PMID： 24847130      PMCID： PMC4031609          DOI： 10.1161/CIRCHEARTFAILURE.113.000981

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  17 in total

1.  Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial.

Authors:  Davide Castagno; Pardeep S Jhund; John J V McMurray; James D Lewsey; Erland Erdmann; Faiez Zannad; Willem J Remme; José L Lopez-Sendon; Philippe Lechat; Ferenc Follath; Christer Höglund; Viacheslav Mareev; Zygmunt Sadowski; Ricardo J Seabra-Gomes; Henry J Dargie
Journal:  Eur J Heart Fail       Date:  2010-03-30       Impact factor: 15.534

2.  Challenges for the basis of practice in heart failure.

Authors:  Lynne Warner Stevenson
Journal:  Circ Heart Fail       Date:  2008-05       Impact factor: 8.790

3.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

4.  Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee.

Authors:  Javed Butler; Justin A Ezekowitz; Sean P Collins; Michael M Givertz; John R Teerlink; Mary N Walsh; Nancy M Albert; Cheryl A Westlake Canary; Peter E Carson; Monica Colvin-Adams; James C Fang; Adrian F Hernandez; Ray E Hershberger; Stuart D Katz; Joseph G Rogers; John A Spertus; William G Stevenson; Nancy K Sweitzer; W H Wilson Tang; Wendy Gattis Stough; Randall C Starling
Journal:  J Card Fail       Date:  2012-04       Impact factor: 5.712

5.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

6.  Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.

Authors:  Mariya P Tokmakova; Hicham Skali; Satish Kenchaiah; Eugene Braunwald; Jean L Rouleau; Milton Packer; Glenn M Chertow; Lemuel A Moyé; Marc A Pfeffer; Scott D Solomon
Journal:  Circulation       Date:  2004-11-29       Impact factor: 29.690

7.  Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial.

Authors:  Marvin A Konstam; James D Neaton; Kenneth Dickstein; Helmut Drexler; Michel Komajda; Felipe A Martinez; Gunter A J Riegger; William Malbecq; Ronald D Smith; Soneil Guptha; Philip A Poole-Wilson
Journal:  Lancet       Date:  2009-11-16       Impact factor: 79.321

8.  The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).

Authors:  Jalal K Ghali; John Wikstrand; Dirk J Van Veldhuisen; Björn Fagerberg; Sidney Goldstein; Ake Hjalmarson; Peter Johansson; John Kjekshus; Lis Ohlsson; Ola Samuelsson; Finn Waagstein; Hans Wedel
Journal:  J Card Fail       Date:  2008-12-23       Impact factor: 5.712

9.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

10.  Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.

Authors:  Inder S Anand; Kalkidan Bishu; Thomas S Rector; Areef Ishani; Michael A Kuskowski; Jay N Cohn
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.